Exactech, Inc., a Gainesville, Florida-based orthopedic implant manufacturer, filed Chapter 11 on October 29, 2024 in the District of Delaware before Judge Laurie Selber Silverstein following large-scale product recalls and mounting product liability exposure. The company, acquired by TPG Capital in a 2018 go-private transaction at $49.25 per share (~$737M), carried approximately $352 million in funded debt at filing and faced near-term maturities on prepetition first lien facilities. Court filings described approximately 2,600 patient product liability lawsuits tied to allegedly non-conforming packaging of orthopedic implant components lacking an oxygen barrier layer, with litigation costs and uncertainty creating an unsustainable capital structure. The debtors obtained $85 million in DIP financing and pursued a plan-integrated going-concern sale process. An investor group (Strategic Value Partners, Stellex Capital Management, and Greywolf Capital Management) was announced as the winning bidder in March 2025. The Fifth Amended Plan was confirmed on September 17, 2025, establishing a Settlement Trust for product liability and recall-related claims and a Commercial GUC Trust. General unsecured recovery was estimated at less than 1%.
